止咳散加减在顽固性咳嗽患者中的应用价值探究  

Application value of Zhike San on intractable cough

作　　者：陈秋旻 伍德娜[2] 苏伟明[1] 刘尊居 陈秋月[1] 

机构地区：[1]厦门大学附属第一医院杏林院区,福建厦门361022 [2]厦门大学附属第一医院,福建厦门361001 [3]厦门市集美区灌口中心卫生院,福建厦门361023

出　　处：《中医临床研究》2018年第28期76-78,共3页Clinical Journal Of Chinese Medicine

摘　　要：目的:探讨止咳散加减在治疗顽固性咳嗽患者的临床应用价值。方法:回顾性选取2015年1月-2017年6月于医院中医科、肺科门诊收治的顽固性患者118例,根据不同的治疗方案分为两组,其中对照组56例患者采用常规西药止咳治疗;研究组62例患者采用止咳散加减治疗,以治疗14d为观察期,比较两组患者的临床治疗效果、咳嗽消失时间、服药治疗时间,同时以半年的随访期调查统计患者的复发情况。结果:(1)在治疗14d后,研究组患者的临床治疗有效率(96.77%)明显高于对照组患者的80.36%(P <0.05);(2)研究组患者的咳嗽消失时间(8.15±1.31)d、药物治疗时间(14.16±2.09)d明显少于对照组患者的(15.78±2.04)d和(21.43±5.27)d(P <0.05);(3)在治疗后半年对患者进行随访发现,研究组患者的复发率为3.23%,明显低于对照组患者的12.50%,(P <0.05)。结论:顽固性咳嗽患者采用止咳散加减治疗具有显著的临床效果,有效减少患者的咳嗽时间和药物治疗时间,对临床治疗有重要的应用价值。Objective:To evaluate the clinical value of Zhike San(止咳散)on intractable cough.Methods:According to the different treatment regimens,118 patients were divided into two groups.56 patients in the control group were treated with conventional western medicine;62 patients in the study group were treated with Zhike San.In 14 days of treatment,the clinical effect,cough disappearance time and medication time between groups were compared.The recurrence in half a year of following period was recorded.Results:The efficacy in the study group was 96.77%,significantly higher than 80.36%in the control group(P<0.05).The time of cough disappearance was(8.15±1.31)days;the treatment time was(14.16±2.09)days in the study group;those were significantly lower than(15.78±2.04)days and(21.43±5.27)days in the control group(P<0.05).The recurrence rate was 3.23%in the study group,and significantly lower than 12.50%in the control group(P<0.05).Conclusion:Zhike San on intractable cough shows a significant effect,can effectively reduce the cough time and treatment time,has important application value.

关 键 词：止咳散加减 顽固性咳嗽 应用价值 

分 类 号：R256.11[医药卫生—中医内科学]